专题：Neuroendocrine Tumor Research Advances

This cluster of papers focuses on the epidemiology, classification, management, and treatment of neuroendocrine tumors, with a specific emphasis on pancreatic neuroendocrine tumors. It covers topics such as somatostatin receptor-based imaging and therapy, MEN1 syndrome, peptide receptor radionuclide therapy, genetic mutations associated with these tumors, and survival analysis.
最新文献
Medullary Thyroid Cancer Risk and Mortality in Carriers of Incidentally Identified MEN2A RET Variants

article Full Text OpenAlex

Characterizing Thyroid Hormone Replacement, Baseline Thyrotropin, and Survival in Immune Checkpoint Inhibitor–Associated Thyroid Dysfunction

article Full Text OpenAlex

Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis

review Full Text OpenAlex

The Role of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Tumors

review Full Text OpenAlex

Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas

article Full Text OpenAlex

Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice

review Full Text OpenAlex

Size matters: Establishing a cut‐off for rectal neuroendocrine neoplasm to predict recurrence and standardize surveillance guidelines

article Full Text OpenAlex

Glucagon-like peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: a Systematic Review and Meta-analysis

review Full Text OpenAlex

Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumors

article Full Text OpenAlex

Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis

review Full Text OpenAlex

近5年高被引文献
Small-cell lung cancer

review Full Text OpenAlex 1114 FWCI32.298

Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors

review Full Text OpenAlex 888 FWCI23.915

Overview of the 2022 WHO Classification of Thyroid Neoplasms

review Full Text OpenAlex 823 FWCI40.163

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

article Full Text OpenAlex 741 FWCI62.406

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

article Full Text OpenAlex 684 FWCI133.454

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

review Full Text OpenAlex 643 FWCI33.25

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

article Full Text OpenAlex 637 FWCI51.548

The Next Decade of Immune Checkpoint Therapy

review Full Text OpenAlex 599 FWCI18.29

Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment

review Full Text OpenAlex 570 FWCI23.853

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

article Full Text OpenAlex 521 FWCI76.413